-
1 Comment
Shandong Weigao Group Medical Polymer Company Limited is currently in a long term uptrend where the price is trading 7.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Finally, its free cash flow fell by 14.4% to $518M since the same quarter in the previous year.
Based on the above factors, Shandong Weigao Group Medical Polymer Company Limited gets an overall score of 2/5.
| CurrencyCode | EUR |
|---|---|
| ISIN | CNE100000171 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Exchange | F |
| PE Ratio | 13.2 |
|---|---|
| Target Price | None |
| Dividend Yield | 4.9% |
| Beta | 0.5 |
| Market Cap | 3B |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The Medical Device Products segment includes safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions. The Orthopedic Products comprises spine, joint, trauma, sports medicine, orthopedic devices, bone repair material, spinal endoscope, PRP treatment consumables, and negative pressure drainage consumables. The Pharma Packaging Products consists prefilled drug delivery system, pharmaceutical packaging consumables, automatic drug delivery system, and pre-filled syringes. The Interventional Products segment offers tumor, vascular, and nursing interventions. The Blood Management Products segment comprises whole blood collection consumables and blood transfusion equipment. The Others segment consists of finance leases and factoring business. The company was founded in 1988 and is based in Weihai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for UK2.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
